Eisai
4523.T
#2336
Rank
S$10.57 B
Marketcap
S$37.48
Share price
2.08%
Change (1 day)
2.49%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. In 2026 the company made an earnings per share (EPS) of S$1.11 a decrease over its 2025 EPS that were of S$1.41.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026S$1.11-21.04%
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.875.52%
2022S$1.77-74.01%
2021S$6.82-66.58%
2020S$20.4198.24%
2019S$10.3017.01%
2018S$8.8037.78%
2017S$6.39-27.62%
2016S$8.8335.33%
2015S$6.52-2.82%
2014S$6.71-27.66%
2013S$9.28-27.49%
2012S$12.80-12.67%
2011S$14.6588.08%
2010S$7.79-11.06%
2009S$8.76-390.15%
2008S-$3.02-127.78%
2007S$10.87347.11%
2006S$2.434.38%
2005S$2.337.4%
2004S$2.1743.03%
2003S$1.5225.09%
2002S$1.2152.67%
2001S$0.7969.76%
2000S$0.47